Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report) shares traded up 9.1% on Friday . The company traded as high as $2.80 and last traded at $2.76. 9,511 shares were traded during trading, a decline of 99% from the average session volume of 842,200 shares. The stock had previously closed at $2.53.
Ampliphi Biosciences Price Performance
Ampliphi Biosciences Company Profile
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Read More
- Five stocks we like better than Ampliphi Biosciences
- How to Capture the Benefits of Dividend Increases
- 3 Stocks Leading the U.S. Agriculture Comeback
- Most active stocks: Dollar volume vs share volume
- How to Use Put Debit Spreads to Profit From Falling Stocks
- What is the FTSE 100 index?
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
